NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the draft criteria for the state-certified community behavioral health clinic demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The letter focuses on the need to finalize a CCBHC framework that is flexible enough to support […]
NAMD submitted comments to the Centers for Medicare and Medicaid Services to inform the development of the prospective payment system (PPS) for the certified community behavioral health clinic (CCBHC) demonstration. This demonstration, which was enacted under the Protecting Access to Medicare Act, will be a 2-year pilot project under which eight states will develop a […]
In this letter, NAMD addressed a variety of issues impacting dually eligible Medicare-Medicaid beneficaries, including the Financial Alignment Demonstrations and Dual Special Needs Plans, in order to enhance the care delivered to this vulnerable population. Read the full letter here. Read CMS’ response letter here.
NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the criteria for the state-certified community behavioral health clinic (CCBHC) demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The comments focus on maximizing participation and success for those states interested in leveraging this opportunity to […]
NAMD contacted CMCS Director Cindy Mann and CMMI Director Dr. Patrick Conway to provide strategic direction for CMS’ Innovation Accelerator Program (IAP). The three overarching themes addressed are: CMS’s technical assistance must be aligned with overall federal agency policy; CMS must be engaged with and focused on Medicaid agencies; and the IAP must be flexible […]
Today the National Association of Medicaid Directors sent the attached letter to the leaders of the Senate Finance and HELP and House Energy & Commerce and Ways & Means committees regarding the current situation with break through prescription drug treatments. The letter addresses the challenges presented by new hepatitis C treatments. It focuses on issues […]
In this letter, the fourth in a series of recommendations to the Center for Medicaid and CHIP Services (CMCS) to inform its ongoing work in modernizing Medicaid managed care regulations, NAMD provides recommendations on quality measure development and implementation. Read the full letter here.
In this letter, the third in a series of recommendations submitted to the Centers for Medicare and Medicaid Services (CMCS), NAMD offers suggestions on ways to ensure robust consumer protections in Medicaid managed care programs. The letter provides recommendations in four main areas: network adequacy, enrollment practices, managed long term services and supports (MLTSS), and […]
NAMD responded to a request for information to inform potential future models to be tested under the Center for Medicare and Medicaid Innovation’s (CMMI) demonstration authority. NAMD lays out six principles to make any model relevant to and feasible for administering in the Medicaid program. Read the full letter here.